Concepedia

Melissa Vrohlings

MV

Statistics

Publications

5

Citations

1.1K

H-Index

5

Active since

2013

Affiliations

University of Zurich(Current)

University Hospital of Zurich

Melissa Vrohlings is an author at University of Zurich specializing in immunology, antitumor t cell responses, and cancer immunotherapy.

Publications per year

2013–2021

5

Publications

5

Sall1 is a transcriptional regulator defining microglia identity and function

Anne Buttgereit, Iva Lelios, Xueyang Yu et al. · Nature Immunology · 2016 · 590 citations

, , +13

Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model

Alexandra Sevko, Tillmann Michels, Melissa Vrohlings et al. · The Journal of Immunology · 2013 · 241 citations · Full text

, , +17

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection

Johannes vom Berg, Melissa Vrohlings, Sergio Haller et al. · The Journal of Experimental Medicine · 2013 · 225 citations · Full text

, , +17

An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus

Armando Zúñiga, Oliver Rassek, Melissa Vrohlings et al. · npj Vaccines · 2021 · 24 citations · Full text

, , +17

Preclinical Assessment of CDR101 - a BCMAxCD3xPD-L1 Trispecific Antibody with Superior Anti-Tumor Efficacy

Melissa Vrohlings, Jan Müller, Stephanie Jungmichel et al. · Blood · 2021 · 15 citations

, , +16

1–5 of 5